Research indicates that orexin levels in MS patients may vary, with some studies reporting lower cerebrospinal fluid orexin-A levels in MS patients with hypothalamic lesions, which are associated with hypersomnia and fatigue [114]. Here, HCRT is linked to hypersomnia.